Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience-Reference-Cited by-同舟云学术

Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience

Published:2020-02-08 Issue:1 Volume:68 Page:222-229
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Oleinikov Kira^ORCID,Uri Inbal,Jacob Harold,Epshtein Julia,Benson Ariel,Ben-Haim Simona,Atlan Karine,Tal Ilanit,Meirovitz Amichay,Maimon Ofra,Lev-Cohain Naama,Mazeh Haggi,Glaser Benjamin,Gross David J.,Grozinsky-Glasberg Simona

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-020-02217-4.pdf

Reference34 articles.

1. S.C. Chandrasekharappa, C.G. Siradanahalli, P. Manickam, S.-E. Olufemi, F.S. Collins, M.R. Emmert-Buck, L.V. Debelenko et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311), 404–407 (1997)

2. R.V. Thakker, Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol. Cell. Endocrinol. 386(1–2), 2–15 (2014)

3. R.V. Thakker, J.N. Paul, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling, S. Melmed, A. Sakurai, F. Tonelli, M.L. Brandi, Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97(9), 2990–3011 (2012).

4. C. Pieterman, E.B. Conemans, K. Dreijerink, J.M. de Laat, M. Timmers, M.R. Vriens, G.D. Valk. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis. Endocr. Relat. Cancer 21(3), R121–R142 (2014)

5. M.C. Lemos, V.T. Rajesh, Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum. Mutat. 29(1), 22–32 (2008)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries;Cancers;2023-10-10

2. Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story;Journal of Endocrinological Investigation;2023-08-15

3. Beyond the “3 Ps”: A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1;Frontiers in Endocrinology;2022-10-17

4. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies;Journal of Endocrinological Investigation;2022-08-30

5. Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review;Pharmaceuticals;2021-10-12